Publications by authors named "Z Cebeci"
The conservation and sustainable utilization of cattle genetic resources necessitate a comprehensive understanding of their genetic diversity and population structure. This study provides an analysis of five native Turkish cattle breeds: Anatolian Black (ANB), Turkish Grey (TUR), Anatolian Southern Yellow (ASY), East Anatolian Red (EAR), and South Anatolian Red (SAN) using 50 K SNP data. These breeds were compared with three European breeds, Simmental (SIM), Holstein (HOL), and Jersey (JER), and three Asian Zebu breeds: Arabic Zebu (ZAR), Nelore (NEL), and Red Sindhi (RSI).
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the effects of sugammadex on cerebral ischemia-reperfusion (I/R) injury in rats, aiming to see if it can help with neurological dysfunction.
- Rats were divided into seven groups, with varying treatments including anesthesia with sevoflurane and rocuronium, to assess sugammadex's impact on brain tissue following I/R damage.
- Results showed that sugammadex significantly reduced apoptotic cell death and oxidative damage markers compared to other treatments, suggesting it may have protective benefits in I/R conditions.
Aims: In this study, we aimed to demonstrate the effectiveness of serum amino-terminal proCNP (NT-proCNP) levels in predicting coronary heart disease (CHD) and cardiovascular risk in type 2 diabetes mellitus (T2DM) patients.
Methods: We recruited 73 patients with T2DM in the study. Additionally, we grouped the patients according to their status of diabetic retinopathy (DR) as no DR, non-proliferative DR, or proliferative DR.
Backgrounds: To evaluate the optical coherence tomography (OCT) biomarkers of patients with central serous chorioretinopathy (CSC) according to the presence or absence of direct anatomical relation to intervortex vein anastomosis (IVA) on indocyanine green angiography.
Methods: We reviewed the records of 39 patients with chronic CSC. Patients were categorized in 2 groups: presence of IVA(Group A) or absence of IVA(Group B) in the macular region.
Article Synopsis
- Treatment began with infliximab and vitreoretinal surgery, but he experienced several adverse reactions, including an infusion reaction, hepatotoxicity, and complications from other therapies.
- After 33 months, despite being in clinical remission, he faced ongoing inflammation in his right eye and had a poor visual acuity, highlighting the need for careful monitoring and adjustments in immunomodulatory treatment for Behçet uveitis.